Position in DHR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$405,912
+$134,642 QoQ
Shares Held
2,131
+79.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,473
of 2,094 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $8,695,472 across 10 Diagnostics & Research names. DHR ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
5,016 | $2,656,423 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
3,112 | $1,638,281 | |
| 3 | ILMN |
Illumina, Inc.
|
6,425 | $1,129,707 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
1,964 | $984,671 | |
| 5 | DGX |
Quest Diagnostics Inc
|
3,946 | $836,354 | |
| 6 | A |
Agilent Technologies, Inc.
|
3,232 | $429,306 | |
| 7 | DHR |
Danaher Corp /De/
This page
|
2,131 | $405,912 | |
| 8 | CSTL |
Castle Biosciences Inc
|
15,932 | $379,978 |
All Filings in DHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $405,912 | 2,131 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $271,270 | 1,185 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $265,668 | 1,340 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $192,601 | 975 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $314,470 | 1,534 | Shares | Sole | 2025-05-05 | |
| 2024-09-30 | $438,159 | 1,576 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $405,756 | 1,624 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $403,547 | 1,616 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||